• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Five questions for venture capital in Q3

September 28, 2021 by David Barret Leave a Comment

Somehow the third quarter of 2021 is coming to a close. Instead of a period filled with family and friends and fun, in many parts of the world, the COVID era dragged on, leaving us largely working from home and executing more phone calls than impromptu brunches. Alas.

But in the last handful of quarters, COVID and its impacts have proven to be attractive periods for both startup fundraising and growth. The second quarter, for example, saw huge sums of private capital disbursed around the world, partially predicated on underlying performance from startups themselves, and partially thanks to inexpensive capital bolstering venture coffers.


The Exchange explores startups, markets and money.

Read it every morning on Extra Crunch or get The Exchange newsletter every Saturday.


Now, with the third quarter coming to a close, The Exchange is prepping for a lengthy dive into global venture capital results. To kick that off, today we’re asking a series of questions: We want to understand how strong Europe’s third quarter was and if the region can match its prior — stellar — fundraising results. We’re interested in what’s going on with China’s venture capital market in the wake of a host of regulatory changes.

We also want to know if the United States is holding onto its position as the leading global venture capital market, and where in the country capital is flowing the most freely. And we want to know where in Latin America we’re seeing the most fundraising acceleration, along with just how important mega-rounds are to recent, aggregate global totals; are big deals still setting the tone for global venture totals?

Today we’ll explore each question in brief, ahead of what we presume will be a long, multi-part dive into the data once Q3 comes to a close later this week.

Did Europe’s venture scene keep raising record sums?

Our first question for Europe will be whether it managed to match its impressive Q2 results. There are signs that it may have, as France recently celebrated the slightly random but no less significant milestone of “1 billion euros raised in one day.” Our suspicion is that these deals were actually announced in close succession because none of the involved startups wanted to miss out on the spotlight after raising record amounts — $555 million for marketplace platform Mirakl, $680 million for fantasy sports startup Sorare and $209 million for Vestiaire Collective.

As a follow-on, we’ll likely look into whether this has anything to do with Brexit: Is capital simply redirecting out of the U.K.? Our intuition is that it isn’t, since we are still hearing about a lot of activity in London and beyond. But capital that might have kept flowing in that direction could now be going to other places in Europe – so we’ll take a closer look at how widely distributed it is, and also at what’s going on with Euronext in terms of tech IPOs.

What’s going on with China’s venture capital market?

Recent regulatory shifts have remade China’s technology landscape. Tech giants have been brought to heel, and rule changes to edtech, social media, gaming and other varietals have shaken both tech companies and other industries in the country. Despite all that, it isn’t hard to find commentary discussing the possible positive impact on China’s economy thanks to the new set of rules.

Source Link Five questions for venture capital in Q3

David Barret
David Barret

Related posts:

  1. New migrant caravan sets off for U.S. from southern Mexico
  2. Riley Moss returns two INTs for scores as No. 18 Iowa routs No. 17 Indiana
  3. Tallest teen, fastest hair skipping among 2022 Guinness World Records
  4. Exclusive-Warburg Pincus seeks $16 billion for private equity fund -sources

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • There Are 23 Countries in North America: Do You Know Them All?
  • “Non-Gravitational Acceleration” Of Interstellar Object 3I/ATLAS Explained In New Study
  • Antiperspirant Before Bed, Or In The Morning? There Is A Right Answer
  • When Did Dogs Become Dogs? Familiar Forms Started To Arise Over 10,000 Years Ago
  • At 900 Meters Across, Earth’s Largest Modern Impact Crater Has Just Been Found By Scientists
  • The First Black Holes May Be From 1 Second After The Big Bang, Before Atoms Existed
  • “The Universe Will Just Get Colder And Deader From Now On” Major Euclid Survey Of The Cosmos Shows
  • Spiders Make “Scarecrows” Of Bigger Spiders Out Of Silk And Debris To Ward Off Predators
  • Having Sex Could Help Physical Injuries Heal Faster – But There’s A Catch
  • How To Win At Rock-Paper-Scissors: A Deep Dive Into Manual Warfare
  • Turns Out, The World’s Most Famous Star Cluster Is Just Part Of A Vast Family Of Stars
  • Watch First-Ever Video Footage Of A Humpback Whale Calf Nursing Underwater
  • People Are Blown Away Learning That You Can “Smell” Snow
  • New Bee Species With A Devilish Name Sports Horns On Its Head Like A Tiny Demon
  • The World’s Smallest Bear Isn’t Just A Guy In A Bear Suit, We Promise
  • Vowel Sounds “Thought To Be Unique To Humans” Discovered In Sperm Whales For The First Time
  • Bizarre Creature With “All-Body Brain” Challenges What We Know About Evolution of Nervous Systems
  • For First Time, Astronomers Record A Coronal Mass Ejection From A Star That’s Not Our Sun
  • In 2032, Earth May Be Treated To A Meteor Shower Like No Other, Courtesy Of “City-Killer” Asteroid 2024 YR4
  • “A Wave Of Poo”: People Reversed The Direction Of The Chicago River’s Flow In 1900
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version